Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
michael.miller@cmd.ox.ac.uk

Research groups

Chemical Biology

Michael Miller

Post Doctoral Research Scientist

Dr. Michael Miller is a postdoctoral researcher working at the University of Oxford in the Centre of Medicines Discovery. He is currently developing phenotypic, cellular, and biochemical assays for both exploratory and compound screening purposes. Michael completed his doctorate at University of Newcastle, Australia where he was researching bacterial transcription and developing compounds that target transcription for the purpose of creating new antibiotics.

Recent publications

Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm.

Kuppusamy R. et al, (2023), Antibiotics (Basel), 12

Tuning the enzyme-like activities of cerium oxide nanoparticles using a triethyl phosphite ligand.

Yadav N. et al, (2022), Biomater Sci, 10, 3245 - 3258

Inhibitors of bacterial RNA polymerase transcription complex.

Wenholz DS. et al, (2022), Bioorg Chem, 118

Multiple classes and isoforms of the RNA polymerase recycling motor protein HelD.

Larsen JS. et al, (2021), Microbiologyopen, 10

RNA polymerases from low G+C gram-positive bacteria.

Miller M. et al, (2021), Transcription, 12, 92 - 102

More publications